Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting Mar 28, 2026 Mar 28, 2026 Updated 7 mins ago Facebook Twitter WhatsApp SMS Email Print Copy article link Save As featured on Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting SAN FRANCISCO, March 28, 2026 Facebook Twitter WhatsApp SMS Email Print Copy article link Save Sections AutomotiveBridalBusiness And CareersCommunity CaresEducationEspanolFamily LivingFashion, Beauty & FitnessFood, Recipes & EntertainingGift IdeasGreen LivingHealth & WellnessHome DecoratingHome ImprovementHot TopicsHow ToKitchen, Bed & BathLawn & GardenMoney & FinancePetsPress ReleasesReal EstateSeasonalSenior LivingSportsTech Talk & InnovationTravel
Data from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting SAN FRANCISCO, March 28, 2026
